Filing Details
- Accession Number:
- 0001645627-17-000054
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-05 12:07:53
- Reporting Period:
- 2017-05-03
- Filing Date:
- 2017-05-05
- Accepted Time:
- 2017-05-05 12:07:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
| Purchased: | 20,000 shares | Avg. Price: $0.08 | Total Value: $1,536.70 |
| Number of Shares After Transactions: | 20,628,949 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,609,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,610,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,611,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,612,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,613,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,614,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,615,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,616,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.07 | 20,617,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.07 | 20,618,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.07 | 20,619,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.07 | 20,620,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.07 | 20,621,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.07 | 20,622,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.07 | 20,623,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 936 | $0.08 | 20,624,885 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 64 | $0.08 | 20,624,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,625,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,626,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,627,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-03 | 1,000 | $0.08 | 20,628,949 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
